Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Haycox

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
British Journal of Clinical Pharmacology|November 18, 2003
Diltiazem co-treatment in renal transplant patients receiving microemulsion cyclosporinCyrus R Kumana, Matthew K L Tong, Chun-Sang Li, et al.
Lancet (London, England)|July 3, 2017
Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trialShuchita Mundle, Hillary Bracken, Vaishali Khedikar, et al.
BMC Research Notes|September 11, 2021
The Induction with Foley OR Misoprostol (INFORM) Study dataset. A dataset of 602 women with hypertensive disease in pregnancy, in India, randomised to either Foley catheter or oral misoprostol for induction of labourShuchita Mundle, Hillary Bracken, Vaishali Khedikar, et al.
BMC Health Services Research|June 10, 2010
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payersJakub Adamski, Brian Godman, Gabriella Ofierska-Sujkowska, et al.
The Lancet. Infectious Diseases|August 30, 2018
Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort studyFiona McGill, Michael J Griffiths, Laura J Bonnett, et al.
Pharmacoeconomics|August 25, 2017
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and ImplicationsAlessandra Ferrario, Diāna Arāja, Tomasz Bochenek, et al.
Frontiers in Pharmacology|October 14, 2016
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive PathwaysMichael Ermisch, Anna Bucsics, Patricia Vella Bonanno, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 31, 2019
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTAPatricia Vella Bonanno, Anna Bucsics, Steven Simoens, et al.
Frontiers in Pharmacology|September 8, 2017
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential ImplementationPatricia Vella Bonanno, Michael Ermisch, Brian Godman, et al.
BMC Medicine|August 15, 2013
Personalizing health care: feasibility and future implicationsBrian Godman, Alexander E Finlayson, Parneet K Cheema, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
British Journal of Clinical Pharmacology|November 18, 2003
Diltiazem co-treatment in renal transplant patients receiving microemulsion cyclosporinCyrus R Kumana, Matthew K L Tong, Chun-Sang Li, et al.
Lancet (London, England)|July 3, 2017
Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trialShuchita Mundle, Hillary Bracken, Vaishali Khedikar, et al.
BMC Research Notes|September 11, 2021
The Induction with Foley OR Misoprostol (INFORM) Study dataset. A dataset of 602 women with hypertensive disease in pregnancy, in India, randomised to either Foley catheter or oral misoprostol for induction of labourShuchita Mundle, Hillary Bracken, Vaishali Khedikar, et al.
BMC Health Services Research|June 10, 2010
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payersJakub Adamski, Brian Godman, Gabriella Ofierska-Sujkowska, et al.
The Lancet. Infectious Diseases|August 30, 2018
Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort studyFiona McGill, Michael J Griffiths, Laura J Bonnett, et al.
Pharmacoeconomics|August 25, 2017
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and ImplicationsAlessandra Ferrario, Diāna Arāja, Tomasz Bochenek, et al.
Frontiers in Pharmacology|October 14, 2016
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive PathwaysMichael Ermisch, Anna Bucsics, Patricia Vella Bonanno, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 31, 2019
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTAPatricia Vella Bonanno, Anna Bucsics, Steven Simoens, et al.
Frontiers in Pharmacology|September 8, 2017
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential ImplementationPatricia Vella Bonanno, Michael Ermisch, Brian Godman, et al.
BMC Medicine|August 15, 2013
Personalizing health care: feasibility and future implicationsBrian Godman, Alexander E Finlayson, Parneet K Cheema, et al.
Pageof 5